Xenon Pharmaceuticals Inc. - Common Shares (XENE) by event type
XENE moves most on rating reiterations — a median of -0.32% at 30 minutes across 98 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the XENE overview →
How XENE reacts across 4 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations 1,456 of 2,283 | 24 | -0.07% | 38% | -0.11% |
| Rating reiterations 3,157 of 3,522 | 98 | -0.32% | 42% | -1.25% |
| Price-target raises 1,393 of 1,790 | 21 | -0.12% | 38% | -0.38% |
| Price-target cuts 1,311 of 1,527 | 17 | -0.24% | 41% | -1.36% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 2 further classes were observed with fewer than 10 measured events and are not published.
That’s how XENE usually reacts — get an email when it moves on news →Every name measured for these event types: Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · XENE overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AtriCure, Inc. (ATRC) | 276 | +0.04% | 51% |
| Coherus Oncology, Inc. (CHRS) | 276 | +0.21% | 51% |
| Aclaris Therapeutics, Inc. (ACRS) | 275 | 0.00% | 48% |
| Anika Therapeutics Inc. (ANIK) | 275 | +0.07% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.